TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer Patients.
CONCLUSION: PTX TC>0.05 is a key pharmacokinetic parameter of PTX which should be monitored to optimize individual treatment in patients with solid tumors.
PMID: 29512471 [PubMed - as supplied by publisher]
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Tags: Recent Pat Anticancer Drug Discov Source Type: research
More News: Anemia | Brain | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | China Health | Esophagus Cancer | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Ovarian Cancer | Ovaries | Statistics | Study | Toxicology